Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dare Bioscience

3.20
-0.0600-1.84%
Post-market: 3.10-0.0999-3.12%17:58 EDT
Volume:36.97K
Turnover:117.75K
Market Cap:28.32M
PE:-16.40
High:3.28
Open:3.28
Low:3.09
Close:3.26
Loading ...

DarÉ Bioscience and Rosy Wellness Announce Strategic Collaboration to Educate and Market DarÉ’S Dare to Play Sildenafil Cream

THOMSON REUTERS
·
04 Jun

BUZZ-Australia's Lynas Rare Earths gains on signing rare earths deal with Malaysian co

Reuters
·
30 May

Dare Bioscience Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

BRIEF-Daré Bioscience Reports First Quarter 2025 Financial Results And Provides Company Update

Reuters
·
14 May

Dare Bioscience Q1 EPS $(0.50) Up From $(0.81) YoY, Sales $25.43K Up From $9.30K YoY

Benzinga
·
14 May

Daré Bioscience Reports Q1 2025 Financial Results; Expects Revenue Generation in Q4 2025 as Part of Expanded Commercial Strategy

Reuters
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Dare Bioscience Inc expected to post a loss of 58 cents a share - Earnings Preview

Reuters
·
10 May

Dare Bioscience Inc expected to post a loss of 58 cents a share - Earnings Preview

Reuters
·
02 May

Daré Bioscience to Present at the Fierce Pharma Engage Summit on Breaking Barriers and Building Access: Communicating Bold Moves in Women’s Health Innovation

GlobeNewswire
·
23 Apr

Investors Await Key Employment, Manufacturing Data as US Futures Mixed in Thursday's Premarket

MT Newswires Live
·
17 Apr

Dare Bioscience to present on expanded business strategy at Jones Conference

TIPRANKS
·
07 Apr

Daré Bioscience to Present at the Jones Healthcare and Technology Innovation Conference on Expanded Business Strategy Including Action to Make its Proprietary Sildenafil Cream Formulation Available via Prescription This Year

GlobeNewswire
·
07 Apr

Q4 2024 Dare Bioscience Inc Earnings Call

Thomson Reuters StreetEvents
·
01 Apr

Dare Bioscience Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Apr

Dare Bioscience Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Apr

BRIEF-Daré Bioscience Reports Full Year 2024 Financial Results

Reuters
·
01 Apr

Dare Bioscience expects to start recording revenue, cash flow in Q425

TIPRANKS
·
01 Apr

DarÉ Bioscience Reports Full Year 2024 Financial Results and Provides Company Update

THOMSON REUTERS
·
01 Apr

Dare Bioscience Inc - DarÉ Expects to Start Recording Revenue and Cash Flow in Q4

THOMSON REUTERS
·
01 Apr